EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation

Title
EU Regulatory Pathways for ATMPs: Standard, Accelerated and Adaptive Pathways to Marketing Authorisation
Authors
Keywords
Marketing Authorisation, advanced therapy medicinal product, cell therapy, gene therapy, regulation, conditional approval, accelerated assessment, PRIME, RMAT designation, Sakigake designation
Journal
Molecular Therapy-Methods & Clinical Development
Volume 13, Issue -, Pages 205-232
Publisher
Elsevier BV
Online
2019-01-30
DOI
10.1016/j.omtm.2019.01.010

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started